CMC Strategy Director in Global Quality, AstraZeneca Biologics @ (November 2021 - June 2022)
Head of Product Quality Group at AstraZeneca Biologics @ AstraZeneca Biologics (June 2018 - November 2021)
Director of Corporate Quality @ AstraZeneca Biologics (June 2016 - June 2018)
Director of QA Technology @ (April 2014 - June 2016)
Principal Scientist (Associate Director) @ (January 2009 - June 2014)
Stephan Krause Education
University of Southern California
PhD (Analytical Chemistry, Biochemistry,)
1993-1998
Stephan Krause Skills
21 CFR Part 11
Analytical Chemistry
Analytical Skills
Assay Development
Biopharmaceuticals
Biotechnology
CAPA
CMC
Change Control
Corrective and Preventive Action (CAPA)
Design of Experiments
FDA
GxP
Negotiation
Pharmaceutical Industry
Quality Assurance
Quality System
Regulatory Affairs
Regulatory Requirements
Regulatory Submissions
SOP
Standard Operating Procedure (SOP)
Statistics
Technology Transfer
U.S. Food and Drug Administration (FDA)
V&V
Vaccines
Validation
Technical Support
Biologics
Corrective and Preventive Action Capa
Project Management
u.s. Food and Drug Administration Fda
Services
C++
Standard Operating Procedure Sop
Research
Support
Liaison
Public Speaking
Standard Operating Procedure
u.s. Food and Drug Administration
Corrective and Preventive Action
Stephan Krause Summary
Stephan Krause, based in Gaithersburg, MD, US, is currently a Executive Director, Analytical Science and Technology, Cell Therapy Quality, Bristol Myers Squibb at Bristol Myers Squibb. Stephan Krause brings experience from previous roles at AstraZeneca and AstraZeneca Biologics. Stephan Krause holds a 1993 - 1998 PhD in Analytical Chemistry, Biochemistry, @ University of Southern California. With a robust skill set that includes 21 CFR Part 11, Analytical Chemistry, Analytical Skills, Assay Development, Biopharmaceuticals and more. Stephan Krause has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Stephan Krause?
Find contact details for 700 million professionals.